CJC-1295 With DAC

CJC-1295 with DAC is a synthetic GHRH analog coupled to a Drug Affinity Complex (DAC) that covalently binds to plasma albumin. This extends the half-life from minutes to several days, enabling continuous increased GH/IGF-1 exposure in research models.

The lyophilisate is produced according to high quality standards and verified with HPLC to a purity of ≥ 99%.

Research relevance

• Prolonged GHRH signaling — models where continuous receptor occupation is desirable.
• Albumin binding — research into the pharmacokinetics of albumin-bound peptides.
• Constant IGF-1 levels — study of sustained IGF-1 axis activation rather than pulsatile.
• Comparative studies — often investigated alongside CJC-1295 without DAC for pulsatile vs. tonic GH delivery.

Frequently Asked Questions

What is CJC-1295 with DAC?

It is a GHRH(1-29) analog with a Drug Affinity Complex that binds to plasma albumin. Albumin binding prevents rapid renal clearance, increasing the half-life to 6–8 days in research models.

What is the main difference compared to the DAC-less variant?

The DAC variant provides tonic, continuously elevated GHRH signaling. Mod GRF 1-29 (without DAC) retains the pulsatile natural release characteristics. Both are relevant for different research questions.

What purity is guaranteed?

Every batch is validated by Janoshik Independent Peptide Analytics for HPLC purity ≥ 99%.

How should CJC-1295 with DAC be stored?
Store refrigerated (2–8 °C), protected from light and moisture. The lyophilisate is long-term stable; reconstitution according to standard peptide protocols.

Disclaimer: Intended solely for research purposes. Not intended for human or animal consumption, medical, diagnostic, therapeutic, or cosmetic applications. Buyer is 18+ and confirms the research context.